n Cardiovascular Journal of Africa - Thrombolysis risk prediction : applying the SITS-SICH and SEDAN scores in South African patients : cardiovascular topic
|Article Title||Thrombolysis risk prediction : applying the SITS-SICH and SEDAN scores in South African patients : cardiovascular topic|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of Africa|
|Affiliations||1 Groote Schuur Hospital, 2 Groote Schuur Hospital, 3 Groote Schuur Hospital, 4 Groote Schuur Hospital, 5 University of Cape Town, 6 University of Cape Town, 7 University of Cape Town and 8 University of Cape Town|
|Publication Date||Sep 2014|
|Pages||224 - 227|
|Keyword(s)||Acute ischaemic stroke, Groote Schuur Hospital, Intracranial haemorrhage, Recombinant tissue plasminogen activator, Risk, rTPA, Safe Implementation of Treatment in Stroke - Symptomatic IntraCerebral Haemorrhage risk score, SEDAN, SITS-MOST, South Africa, Stroke and Thrombolysis|
At present, the only specific medical treatment for acute ischaemic stroke is intravenous administration of recombinant tissue plasminogen activator within 4.5 hours of stroke onset. In the last year, two scores for risk stratification of intracranial haemorrhage have been derived from multicentric European trial groups, the Safe Implementation of Treatment in Stroke - Symptomatic IntraCerebral Haemorrhage risk score (SITS-SICH) and the SEDAN score. The aim of this study was to pilot their use in a cohort of patients treated at a South African tertiary hospital.
Prospectively collected data were used from a cohort of 41 patients who underwent thrombolysis at Groote Schuur Hospital from 2000 to 2012. Computerised tomography brain imaging was available for review in 23 of these cases. The SITS-SICH and SEDAN scores were then applied and risk prediction was compared with outcomes.
Two patients suffered symptomatic intracranial haemorrhage (SICH), representing 4.9% (95% CI: 0-11.5%) of the cohort. This was comparable to the SICH rate in both the SITS-SICH (5.1%) and SEDAN (6.5%) cohorts. Patient scores in the Groote Schuur Hospital cohort appeared similar to those of the validation cohorts of both SITS-SICH and SEDAN.
With increasing use of thrombolysis in a resource-constrained setting, these scores represent a potentially useful tool in patient selection of those most likely to benefit from intravenous thrombolysis, reducing risk for SICH and with the added benefit of curtailing cost.
Article metrics loading...